---

...

Wednesday, December 14

Antibiotics Weaken Alzheimer's

DRUGS: Long-term antibiotic treatment decreased Alzheimer's-causing plaques in the lab. It also helped the brain fight inflammation by enhancing the neuroinflammatory activity of microglial cells. Learn how.



Newswise — Long-term treatment with broad spectrum antibiotics decreased levels of amyloid plaques, a hallmark of Alzheimer’s disease, and activated inflammatory microglial cells in the brains of mice in a new study by neuroscientists from the University of Chicago.

The study, published in Scientific Reports, also showed significant changes in the gut microbiome after antibiotic treatment, suggesting the composition and diversity of bacteria in the gut play an important role in regulating immune system activity that impacts progression of Alzheimer’s disease.

New Territory in Brain Health

“We're exploring very new territory in how the gut influences brain health,” said Sangram Sisodia, PhD, Thomas Reynolds Sr. Family Professor of Neurosciences at the University of Chicago and senior author of the study. “This is an area that people who work with neurodegenerative diseases are going to be increasingly interested in, because it could have an influence down the road on treatments.”

Continued below ad... Two of the key features of Alzheimer’s disease are the development of amyloidosis, accumulation of amyloid-ß (Aß) peptides in the brain, and inflammation of the microglia, brain cells that perform immune system functions in the central nervous system. Buildup of Aß into plaques plays a central role in the onset of Alzheimer’s, while the severity of neuro-inflammation is believed to influence the rate of cognitive decline from the disease.

High Doses of Antibiotics

For this study, Sisodia and his team administered high doses of broad-spectrum antibiotics to mice over five to six months. At the end of this period, genetic analysis of gut bacteria from the antibiotic-treated mice showed that while the total mass of microbes present was roughly the same as in controls, the diversity of the community changed dramatically. The antibiotic-treated mice also showed more than a two-fold decrease in Aß plaques compared to controls, and a significant elevation in the inflammatory state of microglia in the brain. Levels of important signaling chemicals circulating in the blood were also elevated in the treated mice.

While the mechanisms linking these changes is unclear, the study points to the potential in further research on the gut microbiome’s influence on the brain and nervous system.

Antibiotics Alter Amyloid

“We don’t propose that a long-term course of antibiotics is going to be a treatment — that’s just absurd for a whole number of reasons,” said Myles Minter, PhD, a postdoctoral scholar in the Department of Neurobiology at UChicago and lead author of the study. “But what this study does is allow us to explore further, now that we’re clearly changing the gut microbial population and have new bugs that are more prevalent in mice with altered amyloid deposition after antibiotics.”

The study is the result of one the first collaborations from the Microbiome Center, a joint effort by the University of Chicago, the Marine Biological Laboratory and Argonne National Laboratory to support scientists at all three institutions who are developing new applications and tools to understand and harness the capabilities of microbial systems across different fields. Sisodia, Minter and their team worked with Eugene B. Chang, Martin Boyer Professor of Medicine at UChicago, and Vanessa Leone, PhD, a postdoctoral scholar in Chang’s lab, to analyze the gut microbes of the mice in this study.

Ideas from Different Fields

Minter said the collaboration was enabling, and highlighted the cross-disciplinary thinking necessary to tackle a seemingly intractable disease like Alzheimer’s. “Once you put ideas together from different fields that have largely long been believed to be segregated from one another, the possibilities are really amazing,” he said.

Sisodia cautioned that while the current study opens new possibilities for understanding the role of the gut microbiome in Alzheimer’s disease, it’s just a beginning step.

“There’s probably not going to be a cure for Alzheimer’s disease for several generations, because we know there are changes occurring in the brain and central nervous system 15 to 20 years before clinical onset,” he said. “We have to find ways to intervene when a patient starts showing clinical signs, and if we learn how changes in gut bacteria affect onset or progression, or how the molecules they produce interact with the nervous system, we could use that to create a new kind of personalized medicine.”

MORE INFORMATION: SOURCE:
  • About the University of Chicago Medicine
    The University of Chicago Medicine & Biological Sciences is one of the nation's leading academic medical institutions. It comprises the Pritzker School of Medicine, a top 10 medical school in the nation; the University of Chicago Biomedical Sciences Division; and the University of Chicago Medical Center, which recently opened the Center for Care and Discovery, a $700 million specialty medical facility. Twelve Nobel Prize winners in physiology or medicine have been affiliated with the University of Chicago Medicine. Visit our research blog at sciencelife.uchospitals.edu and our newsroom at uchospitals.edu/news. Twitter @UChicagoMed, @ScienceLife Facebook.com/UChicagoMed

Comment or Share:

  1. The "gut-brain axis"is one of the most interestings and deeply studied issues in these days.And now,some researchers uses to says that the "gut"is the"second brain"once it function or dysfunction is absolutely linked as a trigger or hasting,anxiety,depression,autism,Parkinson disease,MS,AD,etc.A healthier and safer way to keeps a healthy"second brain(the gut)is taking probiotics and prebiotics that can do the balance between "bad" and "good" bugs in the gut,lowering the leaking of toxins from the gut to the brain.To takes antibiotics as in the text above,without a clear indication to treat infections,can leads to threatening consequences to the health and even to the life.Between dozens and dozens articles about the gut-brain axis,we can read in the article"Modulation of Gut Microbiota–Brain Axis by Probiotics, Prebiotics, and Diet",published in the Journal of Agric,Food Chem,by Zhang and colleagues:"We highlight the advances in modulating brain development and behavior by probiotics, prebiotics, and diet through the gut microbiota–brain axis.A variety of mechanisms including immune,neural,and metabolic pathways may be involved in modulation of the gut microbiota–brain axis.A deeper understanding of the relationship between the gut bacteria and their hosts is implicated in developing microbial-based therapeutic strategies for brain disorders."

    ReplyDelete

Your comments (up to 200 words):